DiaSorin on Tuesday announced it
has completed studies at the Spallanzani Hospital in Rome and
the Policlinico San Matteo in Pavia to launch by the end of
March a rapid-response molecular test to diagnose the novel
coronavirus (Codiv-19).
The test's result will be available within 60 minutes against
the five-seven hours that are currently necessary to identify
the virus, DiaSorin said.
The request to register the test, which will be reportedly
available by the end of March at the Spallanzani and San Matteo
hospitals, will be submitted to the Food and Drug Administration
for the Emergency Use Authorization.
Meanwhile civil service procurement agency CONSIP announced
that it has activated an emergency procedure to buy ventilators
and medical equipment for intensive and sub-intensive care units
for an additional 5,000 places in ICUs.
ALL RIGHTS RESERVED © Copyright ANSA
